Ani Kevorkyan
Overview
Explore the profile of Ani Kevorkyan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Keuleyan E, Todorov T, Donchev D, Kevorkyan A, Vazharova R, Kukov A, et al.
Microorganisms
. 2025 Jan;
13(1).
PMID: 39858946
Recently a resurgence of has arisen, with concerns around the highly virulent M1 lineage. Our aim was to characterize , the immune responses it causes, and to determine the presence...
2.
Komitova R, Kevorkyan A, Golkocheva-Markova E, Atanasova M, Rangelova V, Raycheva R, et al.
J Infect Dev Ctries
. 2024 Feb;
18(1):136-144.
PMID: 38377101
Introduction: Acute hepatitis E virus (HEV) infection is recognized as a zoonosis in several European countries. We describe the characteristics and outcomes of locally acquired acute HEV hepatitis. Methodology: A...
3.
Rangelova V, Kevorkyan A, Raycheva R, Krasteva M
Diagnostics (Basel)
. 2024 Feb;
14(3).
PMID: 38337756
The second most prevalent healthcare-associated infection in neonatal intensive care units (NICUs) is ventilator-associated pneumonia (VAP). This review aims to update the knowledge regarding the incidence of neonatal VAP and...
4.
Kevorkyan A, Golkocheva-Markova E, Raycheva R, Rangelova V, Komitova R, Atanasova M, et al.
Pathogens
. 2023 Oct;
12(10).
PMID: 37887724
Viral hepatitis B and C are widely recognized problems in hemodialysis (HD) patients. There have been increasing reports of the importance of the hepatitis E virus (HEV) in recent years,...
5.
Golkocheva-Markova E, Ismailova C, Kevorkyan A, Raycheva R, Zhelyazkova S, Kotsev S, et al.
Life (Basel)
. 2023 Jun;
13(6).
PMID: 37374127
The prevalence of hepatitis E virus (HEV) in the Bulgarian population remains underestimated. The aim of the present study was to evaluate age and gender trends in HEV prevalence in...
6.
Komitova R, Kevorkyan A, Vasilev P, Golgocheva-Markova E, Atanasova M
Folia Med (Plovdiv)
. 2023 May;
65(2):343-347.
PMID: 37144323
The COVID-19 pandemic has exploded since the first cases were reported in Wuhan in December 2019, engulfing the globe. Many infected individuals are asymptomatic or have a mild or moderate...
7.
Raycheva R, Kevorkyan A, Stoilova Y
Folia Med (Plovdiv)
. 2022 Aug;
64(4):624-632.
PMID: 36045469
Introduction: Varicella is an acute, highly contagious disease, characterised by generalised vesicular exanthema caused by the initial infection with varicella zoster virus (VZV) which usually affects children aged 2 to...
8.
Raycheva R, Rangelova V, Kevorkyan A
Healthcare (Basel)
. 2022 Jun;
10(6).
PMID: 35742032
The concept of improving the quality and safety of healthcare is well known. However, a follow-up question is often asked about whether these improvements are cost-effective. The prevalence of nosocomial...
9.
Rangelova V, Raycheva R, Sariyan S, Kevorkyan A
PLoS One
. 2022 Jun;
17(6):e0269727.
PMID: 35687609
As a member state of the European Union, where vaccines against COVID-19 are available and affordable, Bulgaria reports the lowest immunization coverage and the most pronounced vaccine distrust. The present...
10.
Golkocheva-Markova E, Kevorkyan A, Raycheva R, Ismailova C, Yoncheva V, Tenev T, et al.
Braz J Infect Dis
. 2022 Feb;
26(1):102329.
PMID: 35176255
It is debatable whether HIV-infected patients are at greater risk for hepatitis E virus (HEV) infection compared with healthy subjects. The reported anti-HEV seroprevalence among different groups in Bulgaria varied...